Title:
COMPOUNDS FOR TREATING CYSTIC FIBROSIS
Document Type and Number:
WIPO Patent Application WO/2016/087665
Kind Code:
A3
Abstract:
The present invention relates to compounds of Formula (I) or pharmaceutically acceptable enantiomers, salts, solvates or prodrugs thereof. The invention further relates to the use of the compounds of Formula (I) for the treatment of cystic fibrosis. The invention also relates to a process for manufacturing compounds of Formula (I).
Inventors:
CALLEBAUT ISABELLE (FR)
MORNON JEAN-PAUL (FR)
DECOUT JEAN-LUC (FR)
BECQ FRÉDÉRIC (FR)
LEHN PIERRE (FR)
HOFFMANN BRICE (FR)
BOUCHERLE BENJAMIN (FR)
HAUDECOEUR ROMAIN (FR)
FORTUNE ANTOINE (FR)
BOINOT CLÉMENT (FR)
ALLIOT JULIEN (FR)
MORNON JEAN-PAUL (FR)
DECOUT JEAN-LUC (FR)
BECQ FRÉDÉRIC (FR)
LEHN PIERRE (FR)
HOFFMANN BRICE (FR)
BOUCHERLE BENJAMIN (FR)
HAUDECOEUR ROMAIN (FR)
FORTUNE ANTOINE (FR)
BOINOT CLÉMENT (FR)
ALLIOT JULIEN (FR)
Application Number:
PCT/EP2015/078729
Publication Date:
September 09, 2016
Filing Date:
December 04, 2015
Export Citation:
Assignee:
CENTRE NAT DE LA RECH SCIENT (CNRS) (FR)
UNIVERSITÉ PIERRE ET MARIE CURIE - PARIS 6 (UPMC) (FR)
UNIVERSITÉ PIERRE ET MARIE CURIE - PARIS 6 (UPMC) (FR)
International Classes:
A61K31/4375; A61K31/47; A61K31/505; A61K31/506; A61K31/52; A61P1/18; A61P11/00; C07D239/00; C07D473/00
Domestic Patent References:
| WO2014124230A2 | 2014-08-14 |
Foreign References:
| US20100093677A1 | 2010-04-15 | |||
| FR2876583A1 | 2006-04-21 | |||
| US20110082146A1 | 2011-04-07 |
Other References:
See also references of EP 3226861A2
Attorney, Agent or Firm:
ICOSA (Paris, FR)
Download PDF: